Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT

Takaaki Murakami, Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu, Koji Matsumoto, Nobuya Inagaki

Open source

DOI
10.1210/en.2019-00556
Published
2019-10-15
Container
Endocrinology
Publisher
The Endocrine Society
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/en.2019-00556,
  title = {Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT},
  author = {Takaaki Murakami and Hiroyuki Fujimoto and Naotaka Fujita and Keita Hamamatsu and Koji Matsumoto and Nobuya Inagaki},
  year = {2019},
  journal = {Endocrinology},
  doi = {10.1210/en.2019-00556},
  url = {https://doi.org/10.1210/en.2019-00556}
}

RIS

TY  - JOUR
TI  - Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT
AU  - Takaaki Murakami
AU  - Hiroyuki Fujimoto
AU  - Naotaka Fujita
AU  - Keita Hamamatsu
AU  - Koji Matsumoto
AU  - Nobuya Inagaki
PY  - 2019
JO  - Endocrinology
DO  - 10.1210/en.2019-00556
UR  - https://doi.org/10.1210/en.2019-00556
ER  - 

APA

Murakami, T., Fujimoto, H., Fujita, N., Hamamatsu, K., Matsumoto, K., & Inagaki, N. (2019). Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT. Endocrinology. https://doi.org/10.1210/en.2019-00556

Source records